Evidence map›Paper›PMID 27034464›Full record

ArticleJournal of lipid research2016

Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.

Wieneke Dijk, Anne P Beigneux, Mikael Larsson, André Bensadoun, Stephen G Young, Sander Kersten

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Preventing Metabolic Syndrome in Adolescents Through Exercise.Advances in experimental medicine and biology · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Differential transcriptomic profiling of lipid metabolism and collagen remodeling in fast- and slow-twitch skeletal muscles in aging.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Wieneke DijkNutrition, Metabolism, and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Anne P BeigneuxDepartments of Medicine David Geffen School of Medicine, University of California, Los Angeles, CA.
Mikael LarssonDepartments of Medicine David Geffen School of Medicine, University of California, Los Angeles, CA.
André BensadounDivision of Nutritional Sciences, Cornell University, Ithaca, NY.
Stephen G YoungDepartments of Medicine David Geffen School of Medicine, University of California, Los Angeles, CA Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.
Sander KerstenNutrition, Metabolism, and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands Division of Nutritional Sciences, Cornell University, Ithaca, NY sander.kersten@wur.nl.
University of California, Los Angeles · USCornell University · USWageningen University & Research · NL

Funding

The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
Refining Physiologic Mechanisms for Intravascular Triglyceride MetabolismR01HL087228 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEIGNEUX, ANNE, FONG, LOREN GI · 2007 to 2024
$7.8M
NHLBI NIH HHS P01 HL090553NHLBI NIH HHS R01 HL087228
6 · The paper itself

Abstract

LPL hydrolyzes triglycerides in triglyceride-rich lipoproteins along the capillaries of heart, skeletal muscle, and adipose tissue. The activity of LPL is repressed by angiopoietin-like 4 (ANGPTL4) but the underlying mechanisms have not been fully elucidated. Our objective was to study the cellular location and mechanism for LPL inhibition by ANGPTL4. We performed studies in transfected cells, ex vivo studies, and in vivo studies with Angptl4(-/-) mice. Cotransfection of CHO pgsA-745 cells with ANGPTL4 and LPL reduced intracellular LPL protein levels, suggesting that ANGPTL4 promotes LPL degradation. This conclusion was supported by studies of primary adipocytes and adipose tissue explants from wild-type and Angptl4(-/-) mice. Absence of ANGPTL4 resulted in accumulation of the mature-glycosylated form of LPL and increased secretion of LPL. Blocking endoplasmic reticulum (ER)-Golgi transport abolished differences in LPL abundance between wild-type and Angptl4(-/-) adipocytes, suggesting that ANGPTL4 acts upon LPL after LPL processing in the ER. Finally, physiological changes in adipose tissue ANGPTL4 expression during fasting and cold resulted in inverse changes in the amount of mature-glycosylated LPL in wild-type mice, but not Angptl4(-/-) mice. We conclude that ANGPTL4 promotes loss of intracellular LPL by stimulating LPL degradation after LPL processing in the ER.

Indexed as

AdipocytesAngiopoietin-Like Protein 4AngiopoietinsAnimalsCytoplasmGolgi ApparatusHumansLipoprotein LipaseLipoproteinsMiceMice, KnockoutProteolysisTriglyceridesAngiopoietin-Like Protein 4AngiopoietinsAngptl4 protein, mouseLipoprotein LipaseLipoproteinslipoprotein triglycerideTriglyceridesadipose tissueintracellular processinglipid metabolismvascular biology

Identifiers

PMID27034464
PMCPMC5003152
OpenAlexW2327038295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.